BUSINESSWEEK ONLINE : JULY 17, 2000 ISSUE
[an error occurred while processing this directive] [an error occurred while processing this directive]
INTERNATIONAL -- EUROPEAN BUSINESS Qiagen: Germany's Booming Biotech THE GOAL To be the biotech industry's ''gold standard'' for the basic tools scientists need for genetic research THE STRATEGY To use its unique access to customers' labs to keep abreast of the latest trends in biotech research and quickly adapt its product line to new markets THE HITCH Its sky-high market cap of $6 billion means it has a long way to fall if the biotech market heads south DATA: BUSINESS WEEK _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _ _					RELATED ITEMS ``The Post-Its of the Biotech Industry'' (int'l edition) TABLE: Qiagen: Germany's Booming Biotech INTERACT E-Mail to Business Week Online

Copyright 2000-2009, by The McGraw-Hill Companies Inc. All rights reserved. Terms of Use   Privacy Notice